Abstract
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
Highlights
Parathyroid carcinoma (PCa) is a rare presentation of primary hyperparathyroidism (PHPT), accounting for less than 1% of cases
Prevalence of PHPT was higher in females, and the female preponderance increased with age
We aimed to investigate whether the hCGCb kit from Roche Diagnostics could distinguish PCa patients from primary and secondary hyperparathyroidism
Summary
Parathyroid carcinoma (PCa) is a rare presentation of primary hyperparathyroidism (PHPT), accounting for less than 1% of cases. We aimed to investigate whether the hCGCb kit from Roche Diagnostics could distinguish PCa patients from primary and secondary hyperparathyroidism. Subjects and methods All patients diagnosed with primary hyperparathyroidism from 1970 to 2014 were included. Aim To validate the accuracy of Ca/P ratio in the diagnosis of Ca-P metabolism disorders, including patients with documented HypoP. We studied the prevalence of SHPT over five years after Roux-en-Y gastric bypass (RYGB) and investigated whether SHPT was associated with serum levels of 25-hydroxyvitamin D (25(OH)D) and ionized calcium (iCa). Results Among the 319 included patients (230 women) the prevalence of SHPT was 32% before surgery, while the prevalence was 18%, 24%, 28% and 35% after a half, one, two and five years, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.